Journal of Behavioral Addictions
Volume/Issue:
Volume 4: Issue 2
Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: Role of enhanced brain reward functional connectivity and homeostasis redeeming joy
Authors:
Thomas McLaughlin Center for Psychiatric Medicine, North Andover, MA, USA

Search for other papers by Thomas McLaughlin in
Current site
Google Scholar
PubMed Close
,
Kenneth Blum Department of Psychiatry and McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA
Department of Clinical Medicine, Malibu Beach Recovery Center, Malibu Beach, CA, USA
Department of Clinical Neurology, PATH Foundation NY, NY, USA
Community Mental Health Institute, Center for Clinical & Translational Science, University of Vermont and Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA
Division of Addiction Services, Dominion Diagnostics, LLC, North Kingstown, RI, USA
Center for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB), Nonakuri, Purbe Medinpur, West Bengal, India
Center for RDS Research, Victory Nutrition, LLC, Austin, TX, USA
Department of Nutrigenomics, RDSolutions, LLC, La Jolla, CA, USA
Department of Personalized Medicine, IGENE, LLC, Austin, TX, USA
Division of Applied Clinical Research, Dominion Diagnostics, LLC, North Kingstown, RI, USA

Search for other papers by Kenneth Blum in
Current site
Google Scholar
PubMed Close
,
Marlene Oscar-Berman Departments of Psychiatry, Neurology, and Anatomy & Neurobiology,, Boston University School of Medicine, and Boston VA Healthcare, Boston, MA, USA

Search for other papers by Marlene Oscar-Berman in
Current site
Google Scholar
PubMed Close
,
Marcelo Febo Department of Psychiatry and McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA

Search for other papers by Marcelo Febo in
Current site
Google Scholar
PubMed Close
,
Gozde Agan Division of Addiction Services, Dominion Diagnostics, LLC, North Kingstown, RI, USA

Search for other papers by Gozde Agan in
Current site
Google Scholar
PubMed Close
,
James L. Fratantonio Division of Applied Clinical Research, Dominion Diagnostics, LLC, North Kingstown, RI, USA

Search for other papers by James L. Fratantonio in
Current site
Google Scholar
PubMed Close
,
Thomas Simpatico Community Mental Health Institute, Center for Clinical & Translational Science, University of Vermont and Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, USA

Search for other papers by Thomas Simpatico in
Current site
Google Scholar
PubMed Close
, and
Mark S. Gold Department of Psychiatry and McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA
Rivermend Health, LLC, Atlanta, GA, USA

Search for other papers by Mark S. Gold in
Current site
Google Scholar
PubMed Close
Pages:
106–115
Online Publication Date:
Jun 2015
Publication Date:
01 Jun 2015
Article Category:
Research Article
DOI:
https://doi.org/10.1556/2006.4.2015.008
Keywords:
putative complex dopamine agonist; KB220Z; parasomnia; functional brain connectivity; lucid nightmares; Post-Traumatic Stress Disorder (PTSD)
Open access

Background

Lucid dreams are frequently pleasant and training techniques have been developed to teach dreamers to induce them. In addition, the induction of lucid dreams has also been used as a way to ameliorate nightmares. On the other hand, lucid dreams may be associated with psychiatric conditions, including Post-Traumatic Stress Disorder (PTSD) and Reward Deficiency Syndrome-associated diagnoses. In the latter conditions, lucid dreams can assume an unpleasant and frequently terrifying character.

Case presentations

We present two cases of dramatic alleviation of terrifying lucid dreams in patients with PTSD. In the first case study, a 51-year-old, obese woman, diagnosed with PTSD and depression, had attempted suicide and experienced terrifying lucid nightmares linked to sexual/physical abuse from early childhood by family members including her alcoholic father. Her vivid “bad dreams” remained refractory in spite of 6 months of treatment with Dialectical Behavioral Therapy (DBT) and standard pharmaceutical agents which included prazosin, clonidie and Adderall. The second 39-year-old PTSD woman patient had also suffered from lucid nightmares.

Results

The medication visit notes reveal changes in the frequency, intensity and nature of these dreams after the complex putative dopamine agonist KB220Z was added to the first patient’s regimen. The patient reported her first experience of an extended period of happy dreams. The second PTSD patient, who had suffered from lucid nightmares, was administered KB220Z to attenuate methadone withdrawal symptoms and incidentally reported dreams full of happiness and laughter.

Conclusions

These cases are discussed with reference to the known effects of KB220Z including enhanced dopamine homeostasis and functional connectivity of brain reward circuitry in rodents and humans. Their understanding awaits intensive investigation involving large-population, double-blinded studies.

  • Aurora, R. N., Zak, R. S., Auerbach, S. H., Casey, K. R., Chowduri, S., Krippot, A., Maganti, R. K., Ramar, K., Kristo, D. A., Bista, S. R., Lamm, C. I. & Morgenthaler, T. I. (2010). Standards of practice committee on treatment of nightmares. Journalof Clinical Sleep Medicine, 6, 389–401

    • Search Google Scholar
    • Export Citation

  • Blum, K., Chen, A. L., Braverman, E. R., Comings, D. E., Chen, T. J., Arcuri, V., Blum, S. H., Downs, B. W., Waite, R. L., Notaro, A., Lubar, J., Williams, L., Prihoda, T. J., Palomo, T. & Oscar-Berman, M. (2008). Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Journal of Neuropsychiatric Disease and Treatment, 4, 893–918

    • Search Google Scholar
    • Export Citation

  • Blum, K., Chen, T. J., Morse, S., Giordano, J., Chen, A. L., Thompson, J., Allen, C., Smolen, A., Lubar, J., Stice, E., Downs, B. W., Waite, R. L., Madigan, M. A., Kerner, M., Fornari, F. & Braverman, E. R. (2010). Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D2 agonist therapy: Part 2. Postgraduate Medical Journal, 122, 214–226

    • Search Google Scholar
    • Export Citation

  • Blum, K., Femino, J., Teitlebaum, S., Oscar-Berman, M., Giordano, J. & Gold, M. S. (2013). 12 steps program & fellowship:Neurobiology of recovery. New York: Springer Briefs

    • Search Google Scholar
    • Export Citation

  • Blum, K., Gardner, E., Oscar-Berman, M. & Gold, M. (2012). “Liking” and “wanting” linked to Reward Deficiency Syndrome (RDS): Hypothesizing differential responsivity in brain rewardcircuitry. Current Pharmaceutical Design, 18, 113–118

    • Search Google Scholar
    • Export Citation

  • Blum, K., Liu, Y., Wang, W., Wang, Y., Zhang, Y., Oscar-Berman, M., Smolen, A., Febo, M., Han, D., Simpatico, T., Cronjé, F. J., Demetrovics, Z. & Gold, M. S. (2015). rsf MRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgraduate Medical Journal, 127(2), 232–241

    • Search Google Scholar
    • Export Citation

  • Blum, K., Oscar-Berman, M., Femino, J., Waite, R. L., Benya, L., Giordano, J., Borsten, J., Downs, W. B., Braverman, E. R., Loehmann, R., Dushaj, K., Han, D., Simpatico, T., Hauser, M., Barh, D. & McLaughlin, T. J. (2013). Withdrawal from buprenorphine/naloxone and maintenance with a natural dopaminergic agonist: A cautionary note. Journal of Addiction Research and Therapy, 4(2)

    • Search Google Scholar
    • Export Citation

  • Blum, K., Oscar-Berman, M., Stuller, E., Miller, D., Giordano, J., Morse, S., McCormick, L., Downs, W. B., Waite, R. L., Barh, D., Neal, D., Braverman, E. R., Lohmann, R., Borsten, J., Hauser, M., Han, D., Liu, Y., Helman, M. & Simpatico, T. (2012). Neurogenetics and nutrigenomics of neuro-nutrient therapy for Reward Deficiency Syndrome (RDS): Clinical ramifications as a function of molecular neurobiological mechanisms. Journalof Addiction Research and Therapy, 3(5), 139

    • Search Google Scholar
    • Export Citation

  • Febo, M., Blum, K., Liu, Y. & Gold, M. S. (2014). Putative dopamine agonist (KB220Z) enhances resting state functional connectivity in brain reward circuitry. Presentation at Addictions Conference 2014, Aug 4–6, Chicago, USA

    • Search Google Scholar
    • Export Citation

  • Fusar-Poli, P., Perez, J., Broome, M., Borgwardt, S., Placentino, A., Caverzasi, E., Cortesi, M., Veggiotti, P., Politi, P., Barale, F. & McGuire, P. (2007). Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 31, 465–484

    • Search Google Scholar
    • Export Citation

  • Gottesmann, C. (2006). The dreaming sleep stage: A new neurobiological model of schizophrenia? Neuroscience, 140, 1105–1115

  • Gottesmann, C. & Joncas, S. (2000). Letter to the editor: Hypothesis for the neurophysiology of dreaming. Journal of Sleep Reseach, 3, 1–4

    • Search Google Scholar
    • Export Citation

  • Hinton, D. E., Peou, S., Joshi, S., Nickerson, A. & Simon, N. M. (2013). Normal grief and complicated bereavement among traumatized cambodian refugees: Cultural context and the central role of dreams of the dead. Culture, Medicine, and Psychiatry, 37, 427–464

    • Search Google Scholar
    • Export Citation

  • Klinger, E. (1971). Structure and functions of fantasy. 1 st edition (p. 57). New York: Wiley Interscience

  • Kovachy, B., O’Hara, R., Hawkins, N., Gershon, A., Primeau, M. M., Madej, J. & Carrion, V. (2013). Sleep disturbance in pediatric PTSD: Current findings and future directions. Journal of Clinical Sleep Medicne, 9, 501–510

    • Search Google Scholar
    • Export Citation

  • McLaughlin, T., Steinberg, B., Christensen, B., Law, I., Parving, A. & Friberg, L. (2014) Potential language and attentional networks revealed through factor analysis of rCBF data measured with SPECT. Journal of Cerebral Blood Flow & Metabolism, 12(4), 535–545

    • Search Google Scholar
    • Export Citation

  • Mellman, T. A., David, D., Kulick-Bell, R., Hebding, J. & Nolan, B. (1995). Sleep disturbance and its relationship to psychiatric morbidity after Hurricane Andrew. The American Journal of Psychiatry, 152, 1659–1663

    • Search Google Scholar
    • Export Citation

  • Nielson, T. & Levin, R. (2007). Nightmares: A new neurocognitive model. Sleep Medicine Reviews, 11, 295–310

  • Pearson-Fuhrhop, K. M., Dunn, E. C., Mortero, S., Devan, W. J., Falcone, G. J., Lee, P., Holmes, A. J., Hollinshead, M. O., Roffman, J. L., Smoller, J. W., Rosand, J. & Cramer, S. C. (2014) Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. PLoS One, 9(5), e93772

    • Search Google Scholar
    • Export Citation

  • Rosen, J., Reynolds, C. F. 3rd, Yeager, A. L., Houck, P. R. & Hurwitz, L. F. (1991). Sleep disturbances in survivors of the Nazi Holocaust. The American Journal of Psychiatry, 148, 62–66

    • Search Google Scholar
    • Export Citation

  • Schredl, M., Bohusch, C., Kahl, J., Mader, A. & Somesan, A. (2000). The use of dreams in psychotherapy: A survey of psychotherapists in private practice. The Journal of Psychotherapy Practice and Research, 9, 81–87

    • Search Google Scholar
    • Export Citation

  • Sil’kis, I. G. (2006). Role of the basal ganglia in the occurrence of paradoxical sleep dreams (hypothetical mechanism). Zh Vyssh Nerv Deiat Im I P Pavlova, 56, 5–21

    • Search Google Scholar
    • Export Citation

  • Sil’kis, I. G. (2010.) Paradoxical sleep as a tool for understanding the hippocampal mechanisms of contextual memory. Neuroscienceand Behavioral Physiology, 40, 5–19

    • Search Google Scholar
    • Export Citation

  • Solms, M. (2000). Dreaming and REM sleep are controlled by different brain mechanisms. Behavioral and Brain Sciences, 23, 843–850

  • Spoormaker, V. I., Schredl, M. & van den Bout, J. (2006). Nightmares: from anxiety symptom to sleep disorder. Sleep Medicine Reviews, 10, 19–31

    • Search Google Scholar
    • Export Citation

  • Thompson, D. F. & Pierce, D. R. (1999). Drug-induced nightmares. Annals of Pharmacotherapy, 33, 93–98

  • Collapse
  • Expand
Cover Journal of Behavioral Addictions
Journal of Behavioral Addictions
Print ISSN:
2062-5871
Online ISSN:
2063-5303

Dr. Zsolt Demetrovics
Institute of Psychology, ELTE Eötvös Loránd University
Address: Izabella u. 46. H-1064 Budapest, Hungary
Phone: +36-1-461-2681
E-mail: jba@ppk.elte.hu

Indexing and Abstracting Services:

  • Web of Science [Science Citation Index Expanded (also known as SciSearch®)
  • Journal Citation Reports/Science Edition
  • Social Sciences Citation Index®
  • Journal Citation Reports/ Social Sciences Edition
  • Current Contents®/Social and Behavioral Sciences
  • EBSCO
  • GoogleScholar
  • PsycINFO
  • PubMed Central
  • SCOPUS
  • Medline
  • CABI
  • CABELLS Journalytics

2023  
Web of Science  
Journal Impact Factor 6.6
Rank by Impact Factor Q1 (Psychiatry)
Journal Citation Indicator 1.59
Scopus  
CiteScore 12.3
CiteScore rank Q1 (Clinical Psychology)
SNIP 1.604
Scimago  
SJR index 2.188
SJR Q rank Q1

Journal of Behavioral Addictions
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge 990 EUR/article
Effective from  1st Feb 2025:
1400 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%.
Subscription Information Gold Open Access

Journal of Behavioral Addictions
Language English
Size A4
Year of
Foundation		 2011
Volumes
per Year		 1
Issues
per Year		 4
Founder Eötvös Loránd Tudományegyetem
Founder's
Address		 H-1053 Budapest, Hungary Egyetem tér 1-3.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-5871 (Print)
ISSN 2063-5303 (Online)

Senior editors

Editor(s)-in-Chief: Zsolt DEMETROVICS

Assistant Editor(s): Csilla ÁGOSTON

Associate Editors

  • Stephanie ANTONS (Universitat Duisburg-Essen, Germany)
  • Joel BILLIEUX (University of Lausanne, Switzerland)
  • Beáta BŐTHE (University of Montreal, Canada)
  • Matthias BRAND (University of Duisburg-Essen, Germany)
  • Ruth J. van HOLST (Amsterdam UMC, The Netherlands)
  • Daniel KING (Flinders University, Australia)
  • Gyöngyi KÖKÖNYEI (ELTE Eötvös Loránd University, Hungary)
  • Ludwig KRAUS (IFT Institute for Therapy Research, Germany)
  • Marc N. POTENZA (Yale University, USA)
  • Hans-Jurgen RUMPF (University of Lübeck, Germany)

Editorial Board

  • Sophia ACHAB (Faculty of Medicine, University of Geneva, Switzerland)
  • Alex BALDACCHINO (St Andrews University, United Kingdom)
  • Judit BALÁZS (ELTE Eötvös Loránd University, Hungary)
  • Maria BELLRINGER (Auckland University of Technology, Auckland, New Zealand)
  • Henrietta BOWDEN-JONES (Imperial College, United Kingdom)
  • Damien BREVERS (University of Luxembourg, Luxembourg)
  • Wim VAN DEN BRINK (University of Amsterdam, The Netherlands)
  • Julius BURKAUSKAS (Lithuanian University of Health Sciences, Lithuania)
  • Gerhard BÜHRINGER (Technische Universität Dresden, Germany)
  • Silvia CASALE (University of Florence, Florence, Italy)
  • Luke CLARK (University of British Columbia, Vancouver, B.C., Canada)
  • Jeffrey L. DEREVENSKY (McGill University, Canada)
  • Geert DOM (University of Antwerp, Belgium)
  • Nicki DOWLING (Deakin University, Geelong, Australia)
  • Hamed EKHTIARI (University of Minnesota, United States)
  • Jon ELHAI (University of Toledo, Toledo, Ohio, USA)
  • Ana ESTEVEZ (University of Deusto, Spain)
  • Fernando FERNANDEZ-ARANDA (Bellvitge University Hospital, Barcelona, Spain)
  • Naomi FINEBERG (University of Hertfordshire, United Kingdom)
  • Sally GAINSBURY (The University of Sydney, Camperdown, NSW, Australia)
  • Belle GAVRIEL-FRIED (The Bob Shapell School of Social Work, Tel Aviv University, Israel)
  • Biljana GJONESKA (Macedonian Academy of Sciences and Arts, Republic of North Macedonia)
  • Marie GRALL-BRONNEC (University Hospital of Nantes, France)
  • Jon E. GRANT (University of Minnesota, USA)
  • Mark GRIFFITHS (Nottingham Trent University, United Kingdom)
  • Joshua GRUBBS (University of New Mexico, Albuquerque, NM, USA)
  • Anneke GOUDRIAAN (University of Amsterdam, The Netherlands)
  • Susumu HIGUCHI (National Hospital Organization Kurihama Medical and Addiction Center, Japan)
  • David HODGINS (University of Calgary, Canada)
  • Eric HOLLANDER (Albert Einstein College of Medicine, USA)
  • Zsolt HORVÁTH (Eötvös Loránd University, Hungary)
  • Susana JIMÉNEZ-MURCIA (Clinical Psychology Unit, Bellvitge University Hospital, Barcelona, Spain)
  • Yasser KHAZAAL (Geneva University Hospital, Switzerland)
  • Orsolya KIRÁLY (Eötvös Loránd University, Hungary)
  • Chih-Hung KO (Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Taiwan)
  • Shane KRAUS (University of Nevada, Las Vegas, NV, USA)
  • Hae Kook LEE (The Catholic University of Korea, Republic of Korea)
  • Bernadette KUN (Eötvös Loránd University, Hungary)
  • Katerina LUKAVSKA (Charles University, Prague, Czech Republic)
  • Giovanni MARTINOTTI (‘Gabriele d’Annunzio’ University of Chieti-Pescara, Italy)
  • Gemma MESTRE-BACH (Universidad Internacional de la Rioja, La Rioja, Spain)
  • Astrid MÜLLER (Hannover Medical School, Germany)
  • Daniel Thor OLASON (University of Iceland, Iceland)
  • Ståle PALLESEN (University of Bergen, Norway)
  • Afarin RAHIMI-MOVAGHAR (Teheran University of Medical Sciences, Iran)
  • József RÁCZ (Hungarian Academy of Sciences, Hungary)
  • Michael SCHAUB (University of Zurich, Switzerland)
  • Marcantanio M. SPADA (London South Bank University, United Kingdom)
  • Daniel SPRITZER (Study Group on Technological Addictions, Brazil)
  • Dan J. STEIN (University of Cape Town, South Africa)
  • Sherry H. STEWART (Dalhousie University, Canada)
  • Attila SZABÓ (Eötvös Loránd University, Hungary)
  • Hermano TAVARES (Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil)
  • Alexander E. VOISKOUNSKY (Moscow State University, Russia)
  • Aviv M. WEINSTEIN (Ariel University, Israel)
  • Anise WU (University of Macau, Macao, China)

 

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2024 0 43 24
Jul 2024 0 50 11
Aug 2024 0 39 20
Sep 2024 0 22 15
Oct 2024 0 178 27
Nov 2024 0 94 27
Dec 2024 0 14 8